Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Scandinavian Journal of Urology|April 1, 2014
Clinical outcome after endoscopic therapy for occult vesicoureteral reflux in females: preliminary results of a retrospective case seriesRenate Pichler, Isabel Heidegger, Barbara Schlenck, et al.
Urologie (Heidelberg, Germany)|December 23, 2025
[Treatment options in rare urological tumors: potential of molecular tumor boards]Steffen Rausch, Isabel Heidegger, Johannes Linxweiler, et al.
Translational Andrology and Urology|November 22, 2021
KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patientsGeorg Schäfer, Nikola Bednarova, Axel Heidenreich, et al.
Urologia Internationalis|May 18, 2017
Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular CancerIsabel Heidegger, Daniel Porres, Nica Veek, et al.
Anticancer Research|May 31, 2015
PSA Isoforms' Velocities for Early Diagnosis of Prostate CancerIsabel Heidegger, Helmut Klocker, Renate Pichler, et al.
Current Opinion in Urology|February 18, 2025
Redefining prostate cancer care: innovations and future directions in active surveillanceMagdalena Koett, Felix Melchior, Nastasiia Artamonova, et al.
European Journal of Medical Research|October 15, 2016
Long term disease free survival with multimodal therapy in small cell bladder cancerIsabel Heidegger, Gennadi Tulchiner, Georg Schäfer, et al.
Oncotarget|May 10, 2014
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesisIsabel Heidegger, Johann Kern, Philipp Ofer, et al.
Urologia Internationalis|November 17, 2015
Hydronephrosis Predicts Successful Catheter Removal after Painful Urinary Retention - Preliminary Results of a Prospective Single Center StudyIsabel Heidegger, Josef Fritz, Hannes Steiner, et al.
International Journal of Molecular Sciences|November 1, 2017
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical RealityAndreas Pircher, Dominik Wolf, Axel Heidenreich, et al.
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Scandinavian Journal of Urology|April 1, 2014
Clinical outcome after endoscopic therapy for occult vesicoureteral reflux in females: preliminary results of a retrospective case seriesRenate Pichler, Isabel Heidegger, Barbara Schlenck, et al.
Urologie (Heidelberg, Germany)|December 23, 2025
[Treatment options in rare urological tumors: potential of molecular tumor boards]Steffen Rausch, Isabel Heidegger, Johannes Linxweiler, et al.
Translational Andrology and Urology|November 22, 2021
KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patientsGeorg Schäfer, Nikola Bednarova, Axel Heidenreich, et al.
Urologia Internationalis|May 18, 2017
Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular CancerIsabel Heidegger, Daniel Porres, Nica Veek, et al.
Anticancer Research|May 31, 2015
PSA Isoforms' Velocities for Early Diagnosis of Prostate CancerIsabel Heidegger, Helmut Klocker, Renate Pichler, et al.
Current Opinion in Urology|February 18, 2025
Redefining prostate cancer care: innovations and future directions in active surveillanceMagdalena Koett, Felix Melchior, Nastasiia Artamonova, et al.
European Journal of Medical Research|October 15, 2016
Long term disease free survival with multimodal therapy in small cell bladder cancerIsabel Heidegger, Gennadi Tulchiner, Georg Schäfer, et al.
Oncotarget|May 10, 2014
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesisIsabel Heidegger, Johann Kern, Philipp Ofer, et al.
Urologia Internationalis|November 17, 2015
Hydronephrosis Predicts Successful Catheter Removal after Painful Urinary Retention - Preliminary Results of a Prospective Single Center StudyIsabel Heidegger, Josef Fritz, Hannes Steiner, et al.
International Journal of Molecular Sciences|November 1, 2017
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical RealityAndreas Pircher, Dominik Wolf, Axel Heidenreich, et al.
Pageof 16